Lisa Rojkjaer

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cardiff, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Raymond Furey (Attorney-in-Fact)
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Lisa Rojkjaer

Form 4 holding Chief Medical Officer

Viracta Therapeutics, Inc.

Security class
Restricted Stock Units
Shares / value
37,146
Estimated value
$53,862
Report date
25 Feb 2023
Price
$1.45
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Medical Officer

Viracta Therapeutics, Inc.

Security class
Common Stock
Shares / value
48,087
Estimated value
$23,717
Report date
27 Feb 2023
Price
$0.4932
Ownership
Direct
Form 4 holding Chief Medical Officer

Viracta Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
150,000
Estimated value
Report date
16 Mar 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding EVP, Chief Medical Officer

RIGEL PHARMACEUTICALS INC

Security class
Employee Stock Option (right to buy)
Shares / value
7,394
Estimated value
Report date
17 Jun 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Lisa Rojkjaer

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .